Higashimatsuyama, Japan

Yukio Tada


Average Co-Inventor Count = 7.1

ph-index = 5

Forward Citations = 101(Granted Patents)


Location History:

  • Tokushima, JP (1985 - 1987)
  • Honjyo, JP (1990)
  • Higashimatsuyama, JP (1998 - 2001)

Company Filing History:


Years Active: 1985-2001

Loading Chart...
8 patents (USPTO):

Title: Innovations of Yukio Tada in Antitumor Research

Introduction

Yukio Tada is a prominent inventor based in Higashimatsuyama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor agents. With a total of 8 patents to his name, Tada's work has the potential to impact cancer treatment significantly.

Latest Patents

Tada's latest patents focus on novel uracil derivatives that exhibit excellent inhibiting effects on human-derived thymidine phosphorylase and demonstrate notable anti-tumor activity. These inventions include pharmaceutical compositions, anti-tumor potentiators, and antitumor agents that incorporate these innovative compounds. The compounds are represented by specific general formulas, showcasing their unique chemical structures and potential applications in cancer therapy.

Career Highlights

Yukio Tada is currently associated with Taiho Pharmaceutical Company Limited, where he continues to advance his research in pharmaceuticals. His work is characterized by a commitment to developing effective treatments for cancer, leveraging his expertise in medicinal chemistry and pharmacology.

Collaborations

Tada collaborates with esteemed colleagues such as Tetsuji Asao and Shingo Yano. These partnerships enhance the research and development process, fostering innovation and the sharing of ideas within the pharmaceutical community.

Conclusion

Yukio Tada's contributions to antitumor research through his innovative patents highlight his role as a key figure in the pharmaceutical industry. His work not only advances scientific knowledge but also holds promise for improving cancer treatment options in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…